Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
AllerPops Prebiotic Lollipops
- Development stage
- Unknown
- Lead developer
- AllerPops
- Modality
- Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
AllerPops is a prebiotic supplement developed by AllerPops Corp, formulated as lozenges or lollipops to support oral microbiome health and alleviate symptoms of allergic rhinitis. The product contains a blend of natural food ingredients, including sugars, amino acids, fibers, and salts, which act as prebiotics to nourish beneficial oral bacteria such as *Fusobacterium*, *Butyrivibrio*, and *Peptostreptococcus*. These bacteria produce short-chain fatty acids (SCFAs) that are hypothesized to modulate the immune system and address 'Oral Probiotic Deficiency Syndrome' (OPDS). While marketed as a consumer health product, it has been studied in a Phase II clinical trial for sustained allergy relief and modulation of the oral microbiota.
- Brand names
- AllerPopsAllerPops Prebiotic Lollipops
- Other names
- AllerPops Prebiotic Lozenges
Beyond the preview
Go deeper on AllerPops Prebiotic Lollipops.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AllerPops Prebiotic Lollipops.